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Background: The immune system of newborn is generally depressed by impaired production of Th1-cell associated
cytokines, which results in increased susceptibility to intracellular pathogens and poor response to vaccinations. For
avoiding abortion, the maternal and fetal immune systems tend to Th2-cell polarizing cytokines. Besides, IL-12p35 is
a determining factor of the bioactivity of IL-12, which has an important role in the Th1 response. Recently methylated
DNA is known to associate to inhibit transcription. Therefore, we explored the methylation status of CpG sites upstream
of the coding sequence of the IL-12p35 gene to determine whether neonatal peripheral blood mononuclear cell
(PBMC) synthesis lower level of IL-12 is related to methylated DNA.
Results: PBMCs from adults expressed higher levels of IL-12p40 (p = 0.303) and IL-12p70 (p = 0.045) and had a strong
ability to produce IL-12p35 mRNA (p = 0.01). However, there was no difference in the methylation status of CpG sites in
the promoter of IL-12p35 between adults and newborns.
Conclusions: We found that PBMC synthesis of bioactive IL-12p70 was significantly impaired in the neonatal period,
potentially though a reduction in IL-12p35 production. The reeducation in IL-12p35 production might not be due to
methylation of the promoter gene. But, the impairment of IL-12p35 expression during the neonatal period might be
caused by other epigenetic regulation occurs in the chromatin level.
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The immune system of newborns is functionally differ-
ent from that of adults, and its immaturity results in an
increased susceptibility to intracellular pathogens and
poor response to vaccinations [1]. Inherent T cell defects
contribute to the immature immunology of newborns,
and these defects have been reported to be due to im-
paired tyrosine phosphorylation and hypermethylation of
specific sites in the promoter region of the gamma inter-
feron (IFN-γ) gene [2,3]. Furthermore, many factors influ-
ence the Th1/Th2 imbalance in early life. The cytokines
IL-12 and IL-4, acting through signal transducer and acti-
vator of transcription 4 (STAT4) and STAT6, respectively,
are key determinants of the development into mature Th1
or Th2 cells.* Correspondence: gicmbor@ntu.edu.tw
3Graduate Institute of Immunology, National Taiwan University, No. 7
Chung-Shan South Road, Taipei 100, Taiwan
4Graduate Institute of Clinical Medicine, National Taiwan University, Taipei,
Taiwan
Full list of author information is available at the end of the article
© 2014 Chen et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.IL-12 is a heterodimeric cytokine produced primarily
by activated inflammatory cells (monocytes, macro-
phages, neutrophils, microglia and dendritic cells), and
formed by a 35-kDa light chain (known as p35) and a
40-kDa heavy chain (known as p40). It is a pro-inflamma-
tory cytokine that induces the production of IFN-γ, favors
the differentiation of Th1 cells and forms a link between
innate resistance and adaptive immunity. The p40 subunit
of IL-12 is shared by IL-23, a cytokine with similar but
also distinct actions compared with IL-12 [4]. IL-12p40 is
produced in large excess over IL-12 heterodimer [5,6].
Each gene encoding IL-12 is located on different chromo-
some. The highly coordinated expression of p40 and p35
to form the biologically active IL-12 (also called p70) in
the same cell type at the same time is essential for the
initiation of an effected immune response [7]. In the
absence of IL-12p35, p40 is secreted as a monomer
or a homodimer, whereas p35 can be secreted only when
associated with p40 [7].
IL-12 has a central role in Th1 responses [5,8]. Also,
IL-12 has been shown to markedly suppress IL-4-inducedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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in vitro [8]. These studies thus suggest that IL-12, through
its capability of inducing Th1 cells, might be capable of
down-regulating pathological Th2 responses. In addition,
decreased level of IL-12 thus inhibits maternal Th1 activ-
ity which in turn protects the fetus during pregnancy.
Therefore, IL-2, IL-12, and IFN-γ are very rarely detected
in the feto-placental unit, and this will tend to bias the
early life immune response towards a Th2 phenotype.
Although evidences suggest that bioactive IL-12p35 mRNA
is critical for the synthesis of bioactive IL-12p70, the
regulation of IL-12p35 gene transcription remains poorly
characterized [9-11]. Based on several studies, the nu-
clear factor kappa-light-chain-enhancer of activated B
cells (NFκB) pathway activate by microbial antigens
via Toll-like receptors (TLR 4 for lipopolysaccharide)
in a MyD88-dependent manner [12,13]. Then activated
NFκB stimulates transcription of IL-12p35 and p40 gene,
and the initial small amounts of IL-12 stimulate natural
killer cells to produce IFN-γ [14,15]. Together with activ-
ity of IFN-γ and lipopolysaccharide (LPS) also lead to the
activation of Sp1 and its binding site in the p35 promoter
as part of selective remodeling of a single nucleosome
within the −310 to −160 region [16]. Together with innate
and adaptive immune responses stimulate synergistically
the production of IL-12 to sustain the inflammatory event
and cell-mediated immunity against pathogens.
The immaturity of the mononuclear cell compartment
contributes to impaired T cell responses in newborns
[17,18]. By analyzing dendritic cells (DCs) generated from
adherent cord blood mononuclear cells cultured in the
presence of GM-CSF and IL-4, the synthesis of the bio-
active dimeric form of IL-12p70 has been shown to be
profoundly impaired in newborn DCs [17]. The pro-
duction of IL-12p40 in activated professional antigen-
presenting cells is generally in great excess over that of the
p35 chain, making p35 a limiting step in the forma-
tion of bioactive IL-12 [9,10]. In addition, IL-12p35 gene
expression is highly repressed in stimulated neonatal DCs,
whereas the IL-12p40 gene expression was not altered. A
recent study showed that the Sp1#1 binding site is located
in a positioned nucleosome (nuc-2), which is selectively
and rapidly remodeled upon activation of the p35 gene
[16]. The molecular mechanisms responsible for deficient
IL-12p35 gene expression in neonatal DCs is due to pro-
foundly impaired nuc-2 remodeling in neonatal DCs in
response to LPS [19].
There is also compelling evidence that DNA methyla-
tion has a repressive action on gene expression [20].
With regards to the immune system, the low capacity of
naive adult T cells to produce IFN-γ has been associated
with hypermethylation of CpG sites of the IFN-γ gene
[3]. Therefore, the aim of this study was to explore
neonatal PBMC immune responses by LPS stimulationin vitro, and to investigate the methylation status of CpG
sites upstream of the coding sequence of the IL-12p35
gene to determine whether a similar phenomenon is
involved in the deficient IL-12 synthesis by neonatal
PBMCs.
Methods
Culture medium and reagents
The culture medium consisted of RPMI 1640 (Sigma-
Aldrich, St. Louis M0, USA) supplemented with L-glu-
tamine and 10% fetal bovine serum (Sigma-Aldrich).
LPS from Escherichia coli (0128:B12) was purchased
from Sigma-Aldrich. Recombinant human Il-12p40
and IL-12p70 were purchased from BD Biosciences
(OptEIA ELISA sets, BD Biosciences, San Jose, CA).
Subjects
Twenty-one normal full-term newborns delivered at the
obstetric department of Cathay General Hospital, Taiwan,
and 20 healthy laboratory volunteers over 20 years of age
were recruited for this study. Heparinized peripheral
blood was obtained from all of the newborns and adults.
The exclusion criteria were: any systemic disorder that
would affect immune status, current pregnancy or lacta-
tion, and the use of systemic antibiotics or anti-inflamma-
tory medication within 6 months. This study was carried
out with the approval of the Ethics Committee of Cathy
General Hospital, and the parents or guardians of all of
the children provided written informed consent.
Cell preparation and culture
PBMCs were obtained from all samples by centrifugation
over Ficoll-Hypaque gradients. The PBMCs were then
cultured in the culture medium at 2 × 106 cells/ml, and
activated with LPS (100 ng/ml). After culture at 37°C
under 5% CO2 for 24 hours, the culture supernatants
were collected and stored at −20°C until analysis of cyto-
kine production by enzyme-linked immunosorbent assay
(ELISA). In the preliminary experiments, we determined
that IL-12p70 and IL-12p40 levels reached a plateau at
24 hours after stimulation and did not increase further
at 48 hours. For real-time PCR experiments, the cells
were incubated for 3 hours and 6 hours.
Cytokine determination
ELISA kits were purchased for the quantification of
IL-12p40 and IL-12p70 (Pharmingen, BD OptEIA™).
The detection limits were 10 pg/ml and 4 pg/ml, respect-
ively. BD™ Cytometric Bead Array Th1/Th2/Th17 assays
were conducted in the presence of a representative from
the manufacturer. All kits included lyophilized standards
that were reconstituted and diluted at 7 serial concentra-
tions according to the manufacturer’s instructions. The
standards included all recombinant cytokines tested, and
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Bead fluorescence readings were done by flow cytometry
(BD™ FACSCanto II).
Quantification of IL-12p35 and IL-12p40 mRNA levels by
real-time PCR
Total RNA was extracted using Trizol reagent (Invitrogen,
Life Technology) and then reverse-transcribed into cDNA
using random hexamers (SMART RT-PCR kit, BD Biosci-
ences Clontech). Gene expressions were determined in
triplicate by quantitative real-time PCR using SYBR
Gene Expression Assays according to the manufacturer’s
instructions on an ABI 7500Fast system (Applied Biosys-
tems, Life Technology, CA, USA). Amplification of the
endogenous control GAPDH was performed in order to
standardize the amount of sample cDNA added. The
oligonucleotide sequences used for IL-12p35 [GenBank:
NM00082] and p40 [GenBank: NM002187] were: sense
primers, 5’-CAAAACCTGCTG AGGGCCGTCA-3’ and
5’- ATGGAATTTGGTCCACTGATA-3’; antisense pri-
mers, 5’- GGAGGCCAGGCAACTCCCATTAG-3’ and 5’-
TCAGGGTACTCCCAGCTG A-3’, respectively. Threshold
cycle values (calculated by SDS Software for the ABI 7500
Fast system) were converted to the number of mRNA cop-
ies by comparison with the respective standard curve.
DNA samples and bisulfite treatment
Samples of blood are collected in heparin-containing
tubes, and the DNA was purified using a genomic DNA
mini kit (QIAGENE, CA) following the manufacturer’s
recommendations. The DNA was quantified using a
NanoDrop ND-100 Spectrophotometer (Thermo Fisher
Scientific, MA) prior to bisulfite treatment. The DNA
(200 ng/reaction) was then treated with bisulfite using a
QIAGENE® bisulfite kit (QIAGENE, CA), according to
manufacturer’s instructions. The bisulfite-treated DNA
was eluted twice in 10 μl of the manufacturer’s elution
buffer (20 μl final volume) and stored in aliquots at −20°C
until use.
PCR and pyrosequencing
DNA methylation levels at the CpG sites were assessed
using pyrosequencing (Pyromark Q24; Qiagen-Biotage).
In brief, methylated cytosines were protected against a
C→T transition following sodium bisulfite treatment
(EpiTect Bisulfite Kit; Qiagen). Pyrosequencing is a quan-
titative sequencing method allowing for the quantification
(%) of cytosine methylation levels at each CpG site of a
given genomic region. The PCR primers were selected
using the PyroMark Assay Design (version 2.0.1.15;
Qiagen). The PCR and pyrosequencing primers for all three
CpG islands tested within the IL-12p35 promoter gene
locus were: IL-12p35①F: 5’- GGATATGTAAAGTGGGA
GGTA-3’, IL-12p35①R: 5’- CCCACCACCCTAAATCCC-3’(118 bp), and IL-12p35②F: 5’- GGGATTTAGGGTGGTG
GG-3’, IL-12p35②R: 5’- TCCTTCT ATATCTCTCTCTA
CA-3’ (223 bp), and IL-12p35 Seq: 5’- CCCGGGAAAGTC
CT GCCGCCGCGCCTCGGG-3’ (4 CpGs). Pyrosequenc-
ing was performed according to the manufacturer’s instruc-
tion. The PyroMark CpG Assays were used in conjunction
with the PyroMark Q24 system (QIAGENE, CA), and each
pyrosequencing reaction used 20 μl of PCR product. Pyro-
grams were analyzed in “Allele Quantification” mode in
order to determine the percentage of C/T, corresponding
to the percentage of methylated and unmethylated C at
each of the CpG sites.
Statistical analysis
The results were expressed as mean ± standard error of
mean (SEM). Fisher’s exact test and the χ2 test were used
to detect significant differences in categorical variables.
Testing for differences in mean proportions was perfor-
med when appropriate with z tests. The non-parametric
Wilcoxon’s rank sum test was used to detect significant
differences in the median values of continuous variables.
A two-tailed P value of 0.05 or less was considered to be
statistically significant. The data were analyzed using the
STATA SE 10.1 program (STATA Corp, College Station,
TX, USA). Data for each kit were analyzed as recom-
mended by the manufacturer. The cytokine concentration
in each analyte was obtained by interpolating the fluores-
cence intensity of at least a 7-point dilution standard
curve supplied with the kit and calculated by SoftMax®
Pro Data Acquisition & Analysis Software and BD FCAP™
Array Software.
Results
Impaired IL-12 production by neonatal PBMCs
With LPS stimulation, the adult and newborn PBMCs
produced comparable levels of IFN-γ, TNF and IL-6,
whereas the synthesis of IL-17A was below detection
levels in the newborn PBMCs and the production of IL-10
was higher in the adults (Table 1). With regards to IL-12,
the levels of IL-12p40 secreted by the neonatal PBMCs
were lower upon LPS activation (Figure 1). The most
dramatic difference was observed for IL-12p70 which
was produced at much lower levels by the neonatal
PBMCs compared to the adult PBMCs under stimulation
(p = 0.045). Therefore, we confirmed that the neonatal
PBMCs were deficient in the synthesis of IL-12p70.
Impaired IL-12p35 gene transcription in LPS-stimulated
neonatal PBMCs
The production of IL-12p40 and p35 mRNA in response
to LPS stimulation alone was significantly lower in the
neonatal PBMCs compared to the adult PBMCs, whereas
IL-12p35 had a more significant effect (Figure 2). This
indicated that deficient LPS-induced IL-12p70 synthesis
Table 1 Cytokine production by adult and neonatal PBMCs
Cytokines (pg/mL) IL-17A IFN-γ TNF IL-10 IL-6
Adult 2.58 ± 1.84 12.34 ± 7.34 124.38 ± 38.97 1416.74 ± 277.56 18461.11 ± 566.29
Newborn 0 1.37 ± 0.7 251.62 ± 47.18 304.28 ± 92.68 17074.1 ± 1116.47
P value - 0.53 0.055 0.0017* 0.267
Data represent the mean with 2 standard deviations of at least 3 independent experiments on different donors. IL-17A, interleukin 17A; IFN-γ, interferon gamma;
TNF, tumor necrosis factor; IL-10, interleukin 10; IL-6, interleukin 6. *P <0.05.
(a)
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scription of IL-12p35 in combination with IL-12p40.
Difference in methylation patterns
A total of 387 nucleotides, corresponding to the re-
gion −411 to −25 relative to the transcription promoter
of the IL-12p35 gene were amplified. Application of the
optimized conditions to generate IL-12p35 promoter
methylation profiles for 34 CpG sites using whole blood
DNA revealed that the methylation levels were extremely
low. When focusing on the NFκB binding site, the pyro-
sequencing analysis indicated an absence of hyperme-
thylation status on the IL-12p35 promoter region, with a
methylation frequency of 2-6% along the promoter region
(Figure 3).
Discussion
The fetal and neonatal immune systems are strongly
associated with physiological demands, which include
protection against infection, avoidance of potentially
harmful pro-inflammatory/Th1-cell-polarizing responses,
and mediation of the transition between the normallyFigure 1 Interleukin-12 production in peripheral blood
mononuclear cells from adults and neonates. Peripheral blood
mononuclear cells from adults (n = 8) or neonates (n = 10) were
cultured in a 48-well plate (2 × 106 cells/ml) in the presence of
100 ng/ml of lipopolysaccharide. After 24 hours of stimulation,
IL-12 production was evaluated in the culture supernatants using
enzyme-linked immunosorbent assay. The results, obtained by
subtracting the control values from the stimulated values, are
expressed in pg/ml.sterile intra-uterine environment to the foreign antigen-
rich environment of the outside world [21]. Mounting
evidence indicates that the infection-induced production
of pro-inflammatory/Th1-cell-polarizing cytokines, inclu-
ding interleukin-1β (IL-1β) and tumor-necrosis factor(b)
Figure 2 Impaired IL-12p35 mRNA production in
lipopolysaccharide (LPS)-stimulated neonatal peripheral
blood mononuclear cells (PBMCs). (a) IL-12p35 mRNA levels
were determined by real-time PCR. The PBMCs were incubated with
medium alone or stimulated with LPS (1 ng/ml) for 3 hours and
6 hours. IL-12p35 mRNA levels were normalized using endogenous
control GAPDH and compared with the non-stimulated group. (b) The
PBMCs were incubated with medium alone or stimulated with LPS
(1 ng/ml) for the indicated period of time. IL-12p40 mRNA levels were
assessed as described in (a). The results are representative of at least 3
independent experiments performed with different donors.
(a)
(b)
Figure 3 Difference in methylation patterns. (a) Sequence of human IL-12 p35 promoter. The sequences of the PCR used to perform
pyrosequencing are indicated by underline. (b) Whole blood methylation % of IL-12p35 promoter region. Each graphic represents each CpG
island (pos-1, 2, 3 and 4). The percentages of methylation are represented by bars. The black bars represent adult and the white bars represent
newborn percentage of methylation of the IL-12p35 promoter site.
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delivery [22]. The ability of pro-inflammatory cytokines to
induce a spontaneous abortion is likely to be an important
reason for the strong bias of the maternal and fetal im-
mune systems of multiple mammalian species toward
Th2-cell-polarizing cytokines [23,24].
After birth, there is an age-dependent maturation of
the immune response. During the prenatal and postnatal
period, exposure to environmental microbial products
can activate innate immunity which also accelerates the
maturation process. This process occurs particularly if
the exposure is repeated over a period of time [25], dimin-
ishing Th2-cell polarization and/or enhancing Th1-cell
polarization and thereby reducing allergy and atopy, which
is compatible with the hygiene hypothesis [26,27]. Allergic
disease such as atopic asthma has multifactorial origins,
arising from complex interactions between genes and
environment. Recent research has highlighted the possible
influence of antenatal environment on the development ofatopy and asthma [28-30]. The immunological processes
are important during early infancy [31], when the immune
system first directly exposed to environment antigens and
establish the long-term responsiveness. Moreover, the de-
grees of functional competence of immunological system
attained by birth, and the kinetics of the ensuing matur-
ation process during infancy are important determinants
of the nature of early immune response against antigens
[32,33] and of the risk of developing asthma and atopy
later in life.
Previous studies have shown that the capacity of
PBMCs to synthesize bioactive IL-12p70 is markedly
impaired at birth and matures surprisingly slowly during
childhood. The adult level of IL-12p70 synthesis is not
acquired until the age of twelve [34]. Indeed, using real-
time PCR technique, we showed IL-12p35 gene expres-
sion was depressed in neonatal mononuclear cells to that
of adult. It has become clear that IL-12 is not only
required during the initial phases of Th1-cell polarization,
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IFN-γ transcription machinery in Th1 cells [35]. More-
over, the production of IL-12 heterodimer by DCs seems
to be much less dependent on the presence of IFN-γ and
of signals from T cells than is production by phagophages,
although production of IL-12 heterodimer is facilitated by
stimulation through CD40L [11]. Neonatal T cells pro-
liferate relatively poor when stimulated with isolated
allogeneic neonatal DCs but strongly with adult DCs
[36]. While the intrinsic properties of T cells undoubt-
edly contribute to immunological immaturity during the
neonatal period [2,37], it is also clear that many of the
“deficiencies” observed in neonatal immune function
are dependent on antigen-presenting cells (APCs) [38].
Similarly, the reduced capacity of neonatal T cells to
produce Th1-cell-polarizing cytokines, IFN-γ, is markedly
improved when cultured with adult, rather than cord
APCs [39]. These results suggest that neonatal DCs and
APCs lack the capacity to deliver important Th1-cell-
polarizing signals to T cells.
The reasons of these insufficiencies might due to the
both quantitative and qualitative differences between
DCs, monocytes and APCs from newborn and adults.
Qualitative differences in monocytes are evident in
utero, as third-trimester phenotyping of fetal or neonatal
circulating monocytes by flow cytometry has revealed
that human fetal monocytes express lower levels of major
histocompatibility complex class II molecules, which po-
tentially contributes to impaired APC activity [40]. Ac-
cording to above statement, the reduced inflammatory cell
and Th1-cell-polarizing fetal APCs activity are thought to
be necessary to reduce the risk of alloimmune reactions
between mother and fetus, and phenotypic and stimulus-
specific functional immaturities have been reported to be
present at birth in both mice and humans [41,42].
Eukaryotic chromatin structure modification of some
cytokines genes can occur during development and then
persist in the differentiated cell. In human monocytes,
priming of IL-12p35 synthesis was shown to rely on an
alternative TATA-dependent promoter. A constitutively
active CpG-rich promoter region was identified 5’ of the
TATA box in EBV-transformed lymphoblastoid cells [43].
Although, the difference of CpG hypermethylation was
not found between newborns and adults in this report,
impaired nucleosome remodeling of newborn was found
preceded IL-12p35 mRNA synthesis in previous report.
[16] Many aspects of transcription-factor binding to rele-
vant cis-acting elements of IL-12p35 promoter are similar
in the DCs from adults and newborns, but chromatin-
accessibility assays revealed that the LPS-induced nucleo-
some remodeling, required for the effective functioning of
the upstream Sp1 transcription factor sites, was substan-
tially impaired in the neonatal DCs. Therefore, neonatal
IL-12p35 gene transcription is repressed at the chromatinlevel. Of note, the administration of IFN-γ has been re-
ported to be able to restore both nucleosome remodeling
and IL-12p35 gene transcription in vitro, indicating that
modulation of nucleosome remodeling is essential in the
activation of neonatal DCs [19]. Several researches at the
murine IL-12p35 locus revealed that transcription of
IL-12p35 is regulated by chromatin, as a positioned
nucleosome at the promoter overlaps the transcription
factor biding sites [44,45]. Kobayashi et al. used wild type
and IL-10 −/− mice model to investigate the mechanisms
IL-10 inhibits IL-12p35 expression [45]. The results revea-
led that histone deacetylation on the IL-12p35 promoter
might mediate homeostatic effects of IL-10 in macro-
phages. These results seems that histone deacetylases has
an important role of regulation IL-12p35 nucleosome
modification at the promoter site. Further investigation
about IL-12 nucleosome modification of newborn could
focus on histone deacetylation.
Otherwise, our result showed neonatal PBMC pro-
duced higher IL-10 by LPS stimulation. Several studies
have demonstrated higher IL-10 responses in cord blood
compared to adult samples [46,47]; however other stud-
ies have revealed controversial results [48,49]. Vosters
et al. demonstrated that the IL-10 response elicited by
LPS was reduced significantly in cord blood mononuclear
cells compared to adult PBMCs [49], and the deficient
production of IL-10 in response to LPS persisted until
18 months of age. In addition, Belderbos et al. indicated
that adult PBMCs produced higher levels of IL-10 in
response to LPS when stimulated in the presence of
neonatal plasma than in the presence of adult plasma
[47]. Therefore, the higher IL-10 responses in cord blood
may also reflect the impact of factors present in the
plasma [49,50]. In this study, we also showed that isolated
PBMCs which stimulated by LPS produced IFN-γ, TNF
and IL-6 with no significant difference between newborns
and adults.
Conclusions
Childhood clearly represents a critical period in the de-
velopment of immune responsiveness, with important
implications for the development of both infectious and
allergic disorders [34]. In order to gain insight into the
mechanisms responsible for the impaired Th1 responses
in childhood, we examined the methylation status of
IL-12p35 at the promoter region. The results showed
that the capacity of PBMCs to synthesize bioactive
IL-12p70 was markedly impaired in the post-natal period,
and that this was contributed to by depressed IL-12p35
mRNA production. This pattern of reduced IL-12p35
production was observed in response to stimulation with
LPS that initiated the IL-12 gene expression via distinct
mechanisms. The mechanism of development of IL-12-
producing capacity throughout childhood remains unclear,
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contribute to this suppressed function of IL-12p35.
This type of defect may result from other epigenetic
rather than methylation mechanisms, and may take
place in the chromatin level. Both DNA methylation and
histone modifications work together to activate and silence
gene by influencing chromatin structure, and also deter-
mine when and where a gene is expressed during develop-
ment. Exploration the influence of histone deacetylases on
IL-12 gene expression will be the next step. With further
research and understanding of this defect and the contin-
ued development of pharmacological agents that modify
chromatin, epigenetics may become a suitable therapeutic
approach for the treatment of inflammatory cell pathology
in asthmatic and allergic patients.
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